BATS BZX Real-Time Price
As of 11:27am ET
| -0.035 / -1.75%|
The 7 analysts offering 12-month price forecasts for X4 Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 2.60. The median estimate represents a +103.05% increase from the last price of 1.97.
The current consensus among 8 polled investment analysts is to Buy stock in X4 Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.